LifeArc

most citedAn in silico drug repurposing pipeline to identify drugs with the potential to inhibit SARS-CoV-2 replication

5 citations

researchers with a paper here

Counting papers with at most 25 authors, so collaboration author lists do not stand in for the people here.

A. Abraham1 · h 5
Eoghan MacMahon1 · h 2
Justin Barton1 · h 4
Méabh MacMahon1 · h 5
M. Tharmakulasingam1 · h 6
N. Han1 · h 17
Paul Bilokon1 · h 1
Soorin Yim1 · h 3
V. P. Gaddi1 · h 4
W. Hwang1 · h 2

collaborating institutions

Arthritis UKGB1 paper
Birkbeck, University of LondonGB1 paper
Cambridge Centre for AI in MedicineGB1 paper
Imperial College LondonGB1 paper
Institute of Structural and Molecular BiologyGB1 paper
Korea Advanced Institute of Science and TechnologyKR1 paper
Thales (United Kingdom)GB1 paper
University College DublinIE1 paper
University of CambridgeGB1 paper
University of ManchesterGB1 paper
University of SurreyGB1 paper

Showing q-bio.QMShow all

1 paper · 1 filter

q-bio.QM2021★ 5 cited

An in silico drug repurposing pipeline to identify drugs with the potential to inhibit SARS-CoV-2 replication

Méabh MacMahon, Woochang Hwang, Soorin Yim +7

Drug repurposing provides an opportunity to redeploy drugs, which ideally are already approved for use in humans, for the treatment of other diseases. For example, the repurposing…